Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Trifecta Capital Advisors LLC

Trifecta Capital Advisors LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.1% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 12,566 shares of the medical equipment provider’s stock after acquiring an additional 1,052 shares during the quarter. Intuitive Surgical makes up 1.3% of Trifecta Capital Advisors LLC’s portfolio, making the stock its 27th biggest position. Trifecta Capital Advisors LLC’s holdings in Intuitive Surgical were worth $6,224,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the business. Atala Financial Inc bought a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $25,000. Parvin Asset Management LLC bought a new position in Intuitive Surgical in the 4th quarter worth approximately $26,000. Global Financial Private Client LLC grew its holdings in Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 38 shares in the last quarter. BankPlus Trust Department bought a new position in Intuitive Surgical in the 4th quarter worth approximately $28,000. Finally, Hurley Capital LLC bought a new position in Intuitive Surgical in the 4th quarter worth approximately $28,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on ISRG. Royal Bank Of Canada decreased their price target on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a research note on Wednesday, April 23rd. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Thursday, June 5th. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the company a “buy” rating in a research note on Monday, April 14th. Truist Financial decreased their price target on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research note on Wednesday, April 23rd. Finally, Citigroup reaffirmed a “buy” rating and set a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $588.95.

Insider Activity

In other news, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction that occurred on Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at $2,695,113.84. The trade was a 3.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of the business’s stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director now owns 6,371 shares of the company’s stock, valued at $3,312,920. This trade represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 4,998 shares of company stock worth $2,611,577. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Down 0.5%

Shares of NASDAQ ISRG opened at $509.49 on Thursday. Intuitive Surgical, Inc. has a 1-year low of $413.82 and a 1-year high of $616.00. The firm has a market capitalization of $182.61 billion, a P/E ratio of 74.71, a P/E/G ratio of 5.43 and a beta of 1.67. The firm’s 50-day moving average price is $527.31 and its 200-day moving average price is $537.92.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same period in the prior year, the firm posted $1.50 EPS. Equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.